Publications by authors named "Luc Janisset"
Article Synopsis
- Pulmonary embolism is a serious condition that can be life-threatening and requires careful management to assess risk levels.
- Since 2014, European guidelines for managing this condition focus on evaluating the patient's hemodynamic status first, followed by a combined risk assessment using clinical scores, imaging, and cardiac biomarkers.
- This review aims to update readers on the significance of Troponins and BNPs in prognostic evaluation and their role in the current management of pulmonary embolism.
Apixaban is a direct oral anticoagulant (DOAC). Many studies have shown that it shows high pharmacokinetic interindividual and intraindividual variability (IIV). The risk of hemorrhage is a major concern for patients treated with apixaban to undergo an operation or an invasive procedure.
View Article and Find Full Text PDF